{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:21:14Z","timestamp":1756992074491},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T00:00:00Z","timestamp":1446422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00595-015-1268-2","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T05:47:35Z","timestamp":1446443255000},"page":"699-704","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Outcomes of initial surgery in patients with clinical N2 non-small cell lung cancer who met 4 specific criteria"],"prefix":"10.1007","volume":"46","author":[{"given":"Tomohiro","family":"Maniwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Ohde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,2]]},"reference":[{"key":"1268_CR1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF01657924","volume":"5","author":"N Martini","year":"1981","unstructured":"Martini N, Flehinger BJ, Zaman MB, Bettie EJ Jr. Results of surgical treatment in N2 lung cancer. World J Surg. 1981;5:663\u20136.","journal-title":"World J Surg"},{"key":"1268_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5223(19)37318-0","volume":"83","author":"FG Pearson","year":"1982","unstructured":"Pearson FG, DeLarue NC, Ilves R, Todd TR, Cooper JD. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg. 1982;83:1\u201311.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1268_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199401203300301","volume":"330","author":"R Rosell","year":"1994","unstructured":"Rosell R, G\u00f3mez-Codina J, Camps C, Maestre J, Padille J, Cant\u00f3 A, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med. 1994;330:153\u20138.","journal-title":"N Engl J Med"},{"key":"1268_CR4","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1200\/JCO.1995.13.8.1880","volume":"13","author":"KS Albain","year":"1995","unstructured":"Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT 3rd, Weick JK, et al. Concurrent cisplatin\/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol. 1995;13:1880\u201392.","journal-title":"J Clin Oncol"},{"key":"1268_CR5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","volume":"374","author":"KS Albain","year":"2009","unstructured":"Albain KS, Swann RS, Rusch VW, Turrisi AT 3rd, Shepherd FA, Smith C, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 2009;374:379\u201386.","journal-title":"Lancet"},{"key":"1268_CR6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/jnci\/djk093","volume":"99","author":"JP Meerbeeck van","year":"2007","unstructured":"van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst. 2007;99:442\u201350.","journal-title":"J Natl Cancer Inst"},{"key":"1268_CR7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/JTO.0b013e31824c945b","volume":"7","author":"I Yoshino","year":"2012","unstructured":"Yoshino I, Yoshida S, Miyaoka E, Asamura H, Nomori H, Fujii Y, et al. Surgical outcome of stage IIIA-cN2\/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004. J Thorac Oncol. 2012;7:850\u20135.","journal-title":"J Thorac Oncol"},{"key":"1268_CR8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-5223(99)70153-4","volume":"118","author":"K Suzuki","year":"1999","unstructured":"Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Nishiwaki Y. The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. J Thorac Cardiovasc Surg. 1999;118:145\u201353.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1268_CR9","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1200\/JCO.2000.18.16.2981","volume":"18","author":"F Andre","year":"2000","unstructured":"Andre F, Grunenwald D, Pignon JP, Dujon A, Pujol JL, Brichon PY, et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol. 2000;18:2981\u20139.","journal-title":"J Clin Oncol"},{"key":"1268_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0169-5002(01)00207-0","volume":"34","author":"Y Ichinose","year":"2001","unstructured":"Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, Shimizu N, et al. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer. 2001;34:29\u201336.","journal-title":"Lung Cancer"},{"key":"1268_CR11","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1093\/ejcts\/ezt195","volume":"44","author":"T Maniwa","year":"2013","unstructured":"Maniwa T, Okumura T, Isaka M, Nakagawa K, Ohde Y, Kondo H. Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2013;44:e59\u201364.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1268_CR12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1378\/chest.07-1379","volume":"132","author":"LA Robinson","year":"2007","unstructured":"Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW, American College of Chest Physicians. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:243\u201365.","journal-title":"Chest"},{"key":"1268_CR13","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1200\/JCO.2009.24.5050","volume":"28","author":"N Yamamoto","year":"2010","unstructured":"Yamamoto N, Nakagawa K, Nishimura Y, Tsujino K, Satouchi M, Kudo S, et al. Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105. J Clin Oncol. 2010;28:3739\u201345.","journal-title":"J Clin Oncol"},{"key":"1268_CR14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1023\/A:1008328207137","volume":"11","author":"K Kubota","year":"2000","unstructured":"Kubota K, Tamura T, Fukuoka M, Furuse K, Ikegami H, Ariyoshi Y, et al. Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902. Ann Oncol. 2000;11:445\u201350.","journal-title":"Ann Oncol"},{"key":"1268_CR15","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(13)62159-5","volume":"383","author":"NSCLC Meta-analysis Collaborative Group","year":"2014","unstructured":"NSCLC Meta-analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet. 2014;383:1561\u201371.","journal-title":"Lancet"},{"key":"1268_CR16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.athoracsur.2004.02.067","volume":"78","author":"RJ Cerfolio","year":"2004","unstructured":"Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET\u2013CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg. 2004;78:1017\u201323.","journal-title":"Ann Thorac Surg"},{"key":"1268_CR17","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00595-013-0660-z","volume":"44","author":"K Imai","year":"2014","unstructured":"Imai K, Minamiya Y, Saito H, Motoyama S, Sato Y, Ito A, et al. Diagnostic imaging in the preoperative management of lung cancer. Surg Today. 2014;44:1197\u2013206.","journal-title":"Surg Today"},{"key":"1268_CR18","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-5223(99)70246-1","volume":"117","author":"H Asamura","year":"1999","unstructured":"Asamura H, Nakayama H, Kondo H, Tsuchiya R, Naruke T. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg. 1999;117:1102\u201311.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1268_CR19","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0022-5223(98)70045-5","volume":"116","author":"M Okada","year":"1998","unstructured":"Okada M, Tsubota N, Yoshimura M, Miyamoto Y. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection. J Thorac Cardiovasc Surg. 1998;116:949\u201353.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1268_CR20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.lungcan.2010.02.009","volume":"70","author":"K Aokage","year":"2010","unstructured":"Aokage K, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K. Subcarinal lymph node in upper lobe non-small cell lung cancer patients: is selective lymph node dissection valid? Lung Cancer. 2010;70:163\u20137.","journal-title":"Lung Cancer"},{"key":"1268_CR21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/jso.10219","volume":"82","author":"KL Prenzel","year":"2003","unstructured":"Prenzel KL, M\u00f6nig SP, Sinning JM, Baldus SE, Gutschow CA, Grass G, et al. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer. J Surg Oncol. 2003;82:256\u201360.","journal-title":"J Surg Oncol"},{"key":"1268_CR22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejcts.2004.01.025","volume":"25","author":"P Misthos","year":"2004","unstructured":"Misthos P, Sepsas E, Athanassiadi K, Kakaris S, Skottis I. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. Eur J Cardiothorac Surg. 2004;25:502\u20138.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1268_CR23","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jtcvs.2011.08.037","volume":"142","author":"K Yasufuku","year":"2011","unstructured":"Yasufuku K, Pierre A, Darling G, de Perrot M, Waddell T, Johnston M, et al. Prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg. 2011;142:1393\u2013400.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1268_CR24","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1056\/NEJMoa043623","volume":"352","author":"T Winton","year":"2005","unstructured":"Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med. 2005;352:2589\u201397.","journal-title":"N Engl J Med"},{"key":"1268_CR25","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","volume":"26","author":"JP Pignon","year":"2008","unstructured":"Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26:3552\u20139.","journal-title":"J Clin Oncol"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-015-1268-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-015-1268-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-015-1268-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T18:40:09Z","timestamp":1599763209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-015-1268-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,2]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["1268"],"URL":"https:\/\/doi.org\/10.1007\/s00595-015-1268-2","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,2]]}}}